Mathew L. Evins
Chairman & Treasurer, GVN Board
Chairman and CEO of Evins, Ltd.
Letter from the Chairman
Having been privileged to serve as Secretary and Treasurer since the organization’s founding, I am incredibly honored to have been elected Chairman of the Global Virus Network. I could not be more appreciative nor more grateful for the opportunity of working closely with Dr. Gallo and Dr. Bréchot, the GVN team and with my distinguished colleagues on the Board of Directors to advance and further the mission and consequence of the GVN.
The COVID-19 pandemic has conclusively demonstrated the absolute and compelling need for a global and apolitical organization committed to the preparedness, defense and first research response to emerging, existing and unidentified viruses that pose a clear and present threat to public health. The GVN was created to address that threat by coalescing eminent virologists, epidemiologists, infectious disease experts and public health specialists throughout the world, working collaboratively and accretively to advance knowledge about how to identify and diagnose pandemic viruses, mitigate and control how such viruses spread and make us sick, train the next generation of virologists, facilitate the development of drugs, vaccines and treatments to combat them as well as addressing the pervasive and often politicized public disinformation and misinformation. The GVN can and must be the definitive go-to authority and resource to anticipate, respond and mitigate global viral threats, as well as a beacon for advocacy, education, enlightenment and insight based solely upon science.
The GVN is at a critical inflection point. Thanks to the outstanding acumen and expertise as well as the relationships and resources of the members of the GVN’s board of directors, we are now in a position to make the critical and consequential decisions necessary to advance and further the sustainability of the GVN, both financially and operationally, to ensure the future viability of the organization and make sure that the world will never again be unprepared, untrained, ill-equipped and uninformed to deal with pandemic viruses.”
Christian Brechot, MD, PhD
President, Global Virus Network
Lawrence Blatt, PhD Chief Executive Officer & Founder
Marc Bonneville, DVM Scientific & Medical Director, Fondation Mérieux
Tomas Cihlar, PhD
Vice President, Virology, Gilead Sciences, Inc.
Lan Kennedy-Davis Partner with RumbergerKirk, P.A.
Robert C. Gallo, MD Homer & Martha Gudelsky Distinguished Professor in Medicine
Co-Founder and Director Institute of Human Virology at the University of Maryland School of Medicine
Co-Founder of the Global Virus Network & Chair of the GVN’s Scientific Leadership Board
Brett P. Giroir, MD CEO, Altesa BioScience
Dr Rosarii Griffin, BA, HDE, MEd., (UCC), MSc. DPhil. (Oxon), FRSA, DDVS Director, Centre for Global Development at the University of Cork College
William Hall, MD, PhD
Professor in the School of Medicine and Medical Science at University College Dublin.
Vice Chairman, Biotechnology and Pharmaceuticals, Korn Ferry
Yang Liu, Ph.D. Chief Executive Officer and Chief Scientific Officer, OncoImmune
Timothy Moynahan, Esq.
Chairman Emeritus, Board of Directors
G. Richard Olds, MD, MACP President of St. George’s University in Grenada
Peter Palese, PhD Horace W. Goldsmith Professor and Chair Department of Microbiology. Professor, Department of Medicine Icahn School of Medicine at Mount Sinai.
Steven Phillips, MD, MPH Vice President of Science and Strategy, COVID Collaborative
John C Pottage, Jr, M.D.
Retired Chief Medical and Scientific Officer, ViiV Healthcare
Raymond Schinazi, PhD, Hon DSc
Professor of Pediatrics and Director
Laboratory of Biochemical Pharmacology, Emory University
Yiming Shao, MD, PhD Chief Expert on AIDS, Chinese Centre for Disease Control and Prevention
Vice Chair, Chinese Microbiology Society
Dr. Juliette M. Tuakli, MD, MPH
Chair, Board of Trustees, United Way Worldwide (UWW)
Anders Vahlne, MD, PhD
Professor Emeritus in Clinical Virology, Karolinska Institute
Pan Zheng, M.D., Ph.D.
Founder, Senior Vice President and Chief Medical Officer, OncoImmune
725 West Lombard St
Baltimore, MD 21201